Hutchison China MediTech ROE 2014-2019 | HCM
Current and historical return on equity (ROE) values for Hutchison China MediTech (HCM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Hutchison China MediTech ROE for the three months ending June 30, 2019 was 0.00%.
|Hutchison China MediTech ROE - Return on Equity Historical Data
||TTM Net Income
||Return on Equity
||Medical Products Manufacturing
Hutchison China MediTech Limited researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China MediTech Limited is based in Hong Kong.